BRUSSELS, May 16 (Reuters) – The European Commission said on Monday it had not yet taken a final decision on whether to cancel the contract for COVID-19 vaccines with French pharmaceutical group Valneva VLS.PA.
Valneva had warned earlier in the day that the group may have to reassess its financial forecast after the European Commission informed it of its intention to end the advance purchase agreement for its candidate vaccine against COVID-19. 19, which caused Valneva’s share price to plummet. nL6N2X8054
A spokesperson for the European Commission confirmed that it had informed Valneva of its intention to terminate the contract but indicated that the final decision would be taken after consultations between the two parties.
(Report by Francesco Guarascio, French version Tangi Salaün, edited by Matthieu Protard)